Skip to content

taVNS on Pupillary Response and Perceptual Learning

The Effect of Transcutaneous Auricular Vagal Nerve Stimulation (taVNS) on Pupillary Response and Perceptual Learning

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05386563
Enrollment
12
Registered
2022-05-23
Start date
2022-05-18
Completion date
2025-07-09
Last updated
2025-12-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pupillary Response

Brief summary

This study has two parts. The study team will evaluate transcutaneous auricular vagal nerve stimulation (taVNS) and two sham settings during a passive task while measuring pupillary response. Second, the study team will assign either taVNS, sham, or no intervention during a go/no-go task and evaluate perceptual learning over three sessions which will also include measuring the pupillary response and electroencephalogram (EEG).

Interventions

taVNS will be delivered by Digitimer DS7 Constant Current Stimulator (an FDA cleared medical device intended for human nerve and muscle stimulation). Stimulation is delivered via sticky pad electrodes all placed on the left side of the body (cymba concha, earlobe, and ulnar side of the wrist). Stimulation is delivered by a 3000ms pulse train (100us pulse width and 25Hz stimulation frequency). The current applied will be between 0.01uA to 9uA. The intervention will be delivered over the course of four sessions approximately one week apart.

PROCEDURESham Stimulation

Sham stimulation will be delivered by Digitimer DS7 Constant Current Stimulator (an FDA cleared medical device intended for human nerve and muscle stimulation). Stimulation is delivered via sticky pad electrodes all placed on the left side of the body (either earlobe or forearm).

Sponsors

NYU Langone Health
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy individuals 18 to 65 * Normal audiometric testing

Exclusion criteria

* Co-morbidities including cardiomyopathies, arrhythmias * Implantable devices including vagal stimulators, pacemakers * Presence of metallic implants * Pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Change in Time It Takes to Reach 90% of Asymptotic Level PerformanceBaseline, Month 3Will be measured during performance on a go/no-go task.
Change in Overall Mean Peak (Pupillary Response)Baseline, Month 3Pupillary responses will be measured noninvasively using a video camera during a go/no-go task.
Change in Speed of Learning to Perform a Behavioral TaskBaseline, Month 3Will be measured during performance on a go/no-go task.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026